The Drug Companies Avoiding Trump’s Tariffs — For Now

Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some branded drugmakers face a reduced tariff rate, but that could change if they don’t reach a so-called most-favored nation drug price deal. The post The Drug Companies Avoiding Trump’s Tariffs — For Now appeared first on…

Read More

Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M

Vima Therapeutics is expanding to Parkinson’s disease following early clinical results showed proof of concept for its drug in isolated dystonia, a rare neurological movement disorder. The startup says its drug could address the biology underpinning many movement disorders. The post Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M…

Read More